ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.11
+0.16 (1.79%)
At close: Sep 18, 2026, 4:00 PM EDT
9.11
0.00 (0.03%)
After-hours: Sep 18, 2026, 4:29 PM EDT
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $2.04 billion as of September 18, 2026. Its market cap has decreased by -44.93% in one year.
Market Cap
2.04B
Enterprise Value
2.11B
1-Year Change
-44.93%
Ranking
Category
Stock Price
$9.11
ChartMarket Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $2.04B, an increase of 3,973.67%. That is a compound annual growth rate of 33.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.04B | -52.89% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 2.04B |
| Nuvation Bio | 2.04B |
| Vericel | 2.03B |
| Agios Pharmaceuticals | 1.96B |
| GH Research | 1.89B |
| Mesoblast | 1.89B |
| Fortrea Holdings | 1.88B |
| Hemab Therapeutics Holdings | 1.87B |